Skip to Content
Biotechnology and health

Three paralyzed men have walked again after receiving electric jolts to the spine

October 31, 2018

Three men with severe spinal cord injuries have walked for the first time in years after receiving targeted electrical stimulation of the spinal cord. 

Breakthrough: Spinal cord injuries can severely reduce a person’s range of motion or lead to complete leg paralysis. In two new papers published in Nature and Nature Neuroscience, researchers describe implanting electrical stimulators into the damaged spinal cords of three men who all had partial or complete lower-leg paralysis. The stimulators then delivered targeted electric pulses in time with the patients’ walking gait.

The patients wore a series of sensors on their legs and feet that wirelessly communicated to the stimulators as they began to walk. Within a week, the men were able to leave the treadmill and walk on the ground with continued electrical stimulation. After a few months, they regained the ability to walk without any electrical stimulation at all.

Right place, right time: The authors believe their success is a result of the implants’ targeted and timed pulse delivery, which helps patients feel as though the signals are coming from their legs. Previous stimulation studies administered pulses in a way that made it difficult for patients to correctly perceive their limbs.

Progress: The paper follows another advance in September, in which researchers began testing an implanted electrical stimulator and successfully enabled a paralyzed man to walk the length of a football field. Now that the approach has been validated in several individuals, the hope is that it will lead to the development of similar neurotechnologies.

Deep Dive

Biotechnology and health

How scientists traced a mysterious covid case back to six toilets

When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.

An AI-driven “factory of drugs” claims to have hit a big milestone

Insilico is part of a wave of companies betting on AI as the "next amazing revolution" in biology

The quest to legitimize longevity medicine

Longevity clinics offer a mix of services that largely cater to the wealthy. Now there’s a push to establish their work as a credible medical field.

There is a new most expensive drug in the world. Price tag: $4.25 million

But will the latest gene therapy suffer the curse of the costliest drug?

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.